- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02496104
Habituation's Mechanisms in Preterm and Term Infants (HABIPREMA)
February 7, 2023 updated by: University Hospital, Brest
Habituation's Mechanisms in Preterm and Term Infants. Behavioral Evaluation: APIB (Assessment of Preterm Infant's Behavior). Assessment of the Cortical and Vegetative Responses
Each year in France, 7 % of newborns are born preterm (before 37 weeks of gestational age (GA)).
The investigators called very preterm infants those who were born before 33 weeks of GA.
These very preterm infants have a higher risk of developing neurological complications like developmental disabilities or cerebral palsy.
To date, early assessment of these infants is difficult and not reliable enough to detect those who are at risks of developing neurological issues.
Now, the investigators need to identify earlier these infants to provide them interventions to improve their development (physical therapy for example).
Consequently, the investigators are examining a study whose aim is to assess preterm infants habituation.
Habituation is the newborn ability to become familiar with new environmental stimulations (noise, light…).
This habituation allows the newborn to maintain his sleep even at onset of a noise or light.
To study this phenomenon in infants born preterm near to corrected term (around 40 weeks of postnatal GA), will allow us to better understand neurological development of these infants.
The investigators plan to compare habituation skills of preterm infants near to their theorical date of birth (40 weeks of GA) to a population of infants born at term.
The investigators will also study the link between habituation abilities and sleep quality as well as neurodevelopmental outcome at the corrected age of two years old.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29609
- Recruiting
- CHRU de Brest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 days to 2 months (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Preterm infants and term infants born in Brest University Hospital
Description
Inclusion Criteria:
- Preterm infants: preterm infants born from 25 weeks to 32 weeks + 6 days of gestation near to 36 weeks of gestation (corrected postnatal age)
- Term infants: term newborns with a gestational age between 39 and 41 weeks of gestation at day 3 with an Apgar ≥ 1 at 1 minute of life
- For both groups: normal neurological physical examination, written informed consent of the parents
Exclusion Criteria:
- no malformation or chromosomal abnormality, life threatening disease, administration of morphine or sedatives during the 24 hours before the study, context of maternal drug addiction, deafness, no psychoactive drug or anticonvulsivants during the last month of pregnancy for the term newborns, severe neurological disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Preterm infants
Preterm infants born between 25 weeks and 32 weeks + 6 days of gestation
|
Other Names:
|
Term newborns
Infant born at term
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Assessment of the package n°1 of the APIB (Assessment of Premature Infant's Behaviour)
Time Frame: At 40 weeks of postnatal gestational age for the preterm infants and at 3 days old for the term newborns
|
At 40 weeks of postnatal gestational age for the preterm infants and at 3 days old for the term newborns
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Salivary cortisol changes
Time Frame: Before and 30 minutes after the package n°1 of the APIB achievement
|
Before and 30 minutes after the package n°1 of the APIB achievement
|
Oxy and deoxyhemoglobin changes in NIRS (Near-infrared Spectroscopy)
Time Frame: During APIB package n°1 fulfillment
|
During APIB package n°1 fulfillment
|
Heart rate variations
Time Frame: During APIB package n°1 fulfillment
|
During APIB package n°1 fulfillment
|
Oxymetry variations
Time Frame: During APIB package n°1 fulfillment
|
During APIB package n°1 fulfillment
|
Brief Infant Sleep Questionnaire
Time Frame: At 6 and 12 months old (corrected age for the preterm infants)
|
At 6 and 12 months old (corrected age for the preterm infants)
|
Ages and Stages Questionnaire
Time Frame: At 24 months old (corrected age for the preterm infants)
|
At 24 months old (corrected age for the preterm infants)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 9, 2015
Primary Completion (ANTICIPATED)
July 1, 2026
Study Completion (ANTICIPATED)
July 1, 2026
Study Registration Dates
First Submitted
July 9, 2015
First Submitted That Met QC Criteria
July 13, 2015
First Posted (ESTIMATE)
July 14, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
February 9, 2023
Last Update Submitted That Met QC Criteria
February 7, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HABIPREMA - RB 14.059
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Habituation, Psychophysiological
-
The University of Tennessee, KnoxvilleActive, not recruitingHabituationUnited States
-
The University of Tennessee, KnoxvilleCompleted
-
Medical Corps, Israel Defense ForceCompletedMotion Sickness | Seasickness | Habituation | Vestibular Time Constant
-
Ruhr University of BochumCompleted
-
The University of Tennessee, KnoxvilleCompletedHealthy | Food Preferences | Addictive Behavior | Food Habits | HabituationUnited States
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPediatric Obesity | HabituationUnited States
-
University of PittsburghCompletedSleep Disorder | Insomnia | Insomnia, PsychophysiologicalUnited States
-
Kaiser PermanenteCompletedDepressive Disorder | Pain | Drug Abuse | Drug Addiction | Drug Dependence | Drug Use Disorders | Drug Habituation
-
Bastyr UniversityRecruitingDepression | Skin Diseases | Quality of Life | Psoriasis | Anxiety | Psoriasis Vulgaris | Psychological Stress | Physiological Stress | Skin Disorder | Psychophysiological DisorderUnited States
Clinical Trials on Package n°1 of the APIB
-
American Academy of Family PhysiciansTerminatedOsteoarthritis | Gastroesophageal Reflux DiseaseUnited States
-
University of California, San FranciscoCompletedAtrial Fibrillation ParoxysmalUnited States
-
National Taiwan University HospitalCompleted
-
Nottingham University Hospitals NHS TrustKing's College Hospital NHS Trust; The Leeds Teaching Hospitals NHS Trust; Manchester... and other collaboratorsRecruitingRespiratory Tract Diseases | Lung Diseases | Cystic Fibrosis | Genetic Disease | Digestive System Disease | Pancreatic DiseaseUnited Kingdom
-
The University of Texas Health Science Center,...Children's Hospital of Philadelphia; National Institute of Diabetes and Digestive...CompletedHypertension | Chronic Kidney DiseasesUnited States
-
Ege UniversityCompleted
-
Institut de Recherche en Sciences de la Sante,...African Population and Health Research Center; World Health OrganizationCompletedDiagnoses Disease | Syphilis Infection
-
Assistance Publique - Hôpitaux de ParisCompletedHypertension | Pregnancy | Preeclampsia | Intrauterine Growth Retardation | PrimiparityFrance
-
Institut CurieCompleted
-
University Hospital, Strasbourg, FranceRecruitingElectronic CigaretteFrance